Logistics Manufacturing Puerto Rico 
Material Handling & Logistics
OCTOBER 6, 2017
Drugmakers rode out Hurricane Maria in Puerto Rico, but keeping plants running while the devastated island picks up the pieces is likely to be tougher. The industry accounts for roughly a quarter of the island’s gross domestic product, with more than 70 medical-device manufacturing operations and 49 U.S. Boston Scientific Inc.,
GlobalTranz
OCTOBER 30, 2017
Puerto Rico and the islands, unfortunately, were not so fortuitous. More importantly, it highlights the incredibly complex and yet necessary disaster logistics required to help clean up and support communities after major disasters. The key is to have a disaster logistics and emergency plan already in place.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Material Handling & Logistics
JANUARY 8, 2018
To look at what risks will affect the supply chain in 2018, Rob Savitsky of AIR Worldwide ( a member of the MIT Center for Transportation & Logistics Supply Chain Exchange program), wrote a blog for MIT discussing three broad categories of supply chain risk. Natural Catastrophes.
GlobalTranz
NOVEMBER 20, 2017
Sudden growth in the stock market means increases in manufacturing and commerce across the country, and as a result, shippers will have more product to move. Although Amazon owns its logistics network, Amazon sets the standards for other shippers. Increased Market Stamina Contributes to Capacity Crunch Factors.
AFFLINK
DECEMBER 6, 2017
Indeed, 2017 was plagued by problems within international supply chains, ranging from logistical to unethical. Puerto Rico Aid. One of the year's most devastating failures in supply chain planning happened in Puerto Rico after catastrophic Hurricane Maria. Talk about a bottleneck. Apple's iPhone X.
Kinaxis
APRIL 18, 2018
Philippe Hemard, former VP of Logistics Europe for Amazon, discussed what pharma companies need to learn from Amazon: As life expectancy grows, there will be more patients with mobility issues. Francois talked about how cell and gene therapies are personalizing medicine, putting individual patients at the center of the supply network.
Kinaxis
APRIL 18, 2019
Coordinating regulatory approvals with the ability to manufacture could make or break capturing market share. Early approvals could cause a struggle to ramp up manufacturing capabilities. Late approvals may give you more time to prepare manufacturing but could leave you with high capital resources sitting idle.
Expert insights. Personalized for you.
54 
Let's personalize your content